Looking ahead, BMS aims to expand its oncology portfolio by focusing on precision medicine and personalized therapies. The company is also investing in next-generation technologies such as gene editing and nanotechnology to develop more effective cancer treatments. BMS is committed to continuing its leadership in the field of oncology by bringing more innovative therapies to patients worldwide.
